Page last updated: 2024-10-24

carvedilol and Primary Peritonitis

carvedilol has been researched along with Primary Peritonitis in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Carvedilol (CVL) is an α-, β-blocker used to treat high blood pressure and congestive heart failure; however, some benefits beyond decreased blood pressure were observed clinically, suggesting the potential anti-inflammatory activity of CVL."1.48Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome. ( Chen, A; Cheng, CC; Cheng, SM; Hua, KF; Li, LH; Lin, WY; Rao, YK; Wong, WT; Yang, SP, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wong, WT1
Li, LH1
Rao, YK1
Yang, SP1
Cheng, SM1
Lin, WY1
Cheng, CC1
Chen, A1
Hua, KF1

Other Studies

1 other study available for carvedilol and Primary Peritonitis

ArticleYear
Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome.
    Frontiers in immunology, 2018, Volume: 9

    Topics: Adrenergic beta-Antagonists; Animals; Autophagy; Carvedilol; Cell Line; Cytokines; Disease Models, A

2018